Table 2 Perinatal outcome of the studied pregnancies.

From: Circulating EGFL7 distinguishes between IUGR and PE: an observational case–control study

 

Controls N° 34

IUGR N° 34

p-value§

e-PE N° 29

p-value§§

p-value$

l-PE N° 7

p-value§§§

p-value£

Gestational age at delivery (weeks)

39.4 ± 1.3

34.9 ± 3.5

 < 0.0001

32.1 ± 2.1

 < 0.0001

 < 0.0001

37.3 ± 1.1

0.001

 < 0.0001

Birthweight (grams)

3351.8 ± 406.1

1894.4 ± 632.5

 < 0.0001

1271.0 ± 379.5

 < 0.0001

 < 0.0001

2562.8 ± 556.4

 < 0.0001

 < 0.0001

Birthweight centile (Yudkin)

44.2 ± 26.8

7.6 ± 11.7

 < 0.0001

3.6 ± 7.2

 < 0.0001

0.137

20.9 ± 24.1

0.040

 < 0.0001

Apgar 1st minute

8.7 ± 0.8

8.1 ± 1.8

0.094

7.4 ± 1.4

 < 0.0001

0.069

8.0 ± 1.8

0.733

0.005

Apgar 5th minute

9.7 ± 0.5

9.2 ± 1.0

0.014

8.8 ± 0.8

 < 0.0001

0.102

9.4 ± 0.8

0.215

 < 0.0001

  1. §Two-independent sample t-test (IUGR vs. Controls).
  2. §§Two-independent sample t-test (e-PE vs. Controls).
  3. $Two-independent sample t-test (IUGR vs. e-PE).
  4. §§§Two-independent sample t-test (l-PE vs. Controls).
  5. £Anova Test among the four groups (Controls vs. IUGR vs. e-PE vs. l-PE).
  6. IUGR Intrauterine Growth Restriction; PE Preeclampsia; e-PE Early-onset PE; l-PE Late-onset PE.
Back to article page